close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IRIDEX Corporation - Common Stock (NQ:IRIX)

1.190 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IRIDEX Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Iridex Comments on Recent Stock Price Volatility
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
News headline image
Insights into Iridex's Upcoming Earnings ↗
 
Via Benzinga
News headline image
Iridex: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
Iridex's Earnings Outlook ↗
 
Via Benzinga
News headline image
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Comments on Changing Glaucoma Reimbursement Landscape
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Reports Third Quarter 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Appoints Patrick Mercer as Chief Executive Officer
From IRIDEX Corporation
Via GlobeNewswire
News headline image
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q2 2024 ↗
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Iridex Reports Second Quarter 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces Convertible Note Financing
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q1 2024 ↗
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Iridex Reports First Quarter 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023 ↗
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
Advances strategic review to unlock shareholder value 
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Earnings Scheduled For March 26, 2024 ↗
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. 
Via Benzinga
News headline image
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Corporation Receives European Patent on MicroPulse Technology
The Advanced Short Pulse Laser System 
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
From IRIDEX Corporation
Via GlobeNewswire
News headline image
Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
From IRIDEX Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today